Miriam R Raffeld1, Alessandro Biffi1, Thomas W K Battey1, Alison M Ayres1, Anand Viswanathan1, Steven M Greenberg1, Jonathan Rosand1, Christopher D Anderson2. 1. From the Hemorrhagic Stroke Research Group (M.R.R., A.B., T.W.K.B., A.M.A., A.V., S.M.G., J.R., C.D.A.), Division of Neurocritical Care and Emergency Neurology, Department of Neurology (M.R.R., A.B., T.W.K.B., J.R., C.D.A.), and Center for Human Genetic Research (M.R.R., A.B., T.W.K.B., J.R., C.D.A.), Massachusetts General Hospital, Boston. 2. From the Hemorrhagic Stroke Research Group (M.R.R., A.B., T.W.K.B., A.M.A., A.V., S.M.G., J.R., C.D.A.), Division of Neurocritical Care and Emergency Neurology, Department of Neurology (M.R.R., A.B., T.W.K.B., J.R., C.D.A.), and Center for Human Genetic Research (M.R.R., A.B., T.W.K.B., J.R., C.D.A.), Massachusetts General Hospital, Boston. cdanderson@partners.org.
Abstract
OBJECTIVE: Genetic variants ε2/ε4 within the APOE gene are established risk factors for lobar intracerebral hemorrhage (ICH). Published preliminary data suggest a potential role for APOE ε4 in risk of nonlobar ICH. We therefore investigated the role of APOE in recurrent nonlobar ICH, and sought to clarify whether effects of APOE on circulating lipids mediate this association. METHODS: Three hundred sixty-three survivors of nonlobar ICH were followed prospectively for ICH recurrence, with APOE genotype determined at enrollment. All participants had clinical, demographic, and laboratory data captured at time of index ICH and during follow-up. Using a multivariate model, we performed association and interaction analyses of the relationships among APOE genotype, lipid levels, and recurrent nonlobar ICH. RESULTS: We observed 29 nonlobar ICH recurrences among 363 survivors. APOE ε4 was associated with recurrent nonlobar ICH (hazard ratio = 1.31; 95% confidence interval = 1.02-2.69; p = 0.038) after adjustment for age/sex/ethnicity and cardiovascular risk factors. Increasing low-density lipoprotein (LDL) levels were associated with decreased risk of recurrent nonlobar ICH (p = 0.027), as were decreasing HDL levels (p = 0.046). LDL levels modified the association of APOE ε4 with recurrent nonlobar ICH (mediation p < 0.05). No associations were identified between APOE ε2 and recurrent nonlobar ICH. CONCLUSION: APOE ε4 is associated with recurrent ICH in nonlobar brain regions, providing further evidence for its causal role in ICH unrelated to cerebral amyloid angiopathy. LDL levels modulated this effect, suggesting that circulating lipid levels may mediate a portion of the role of APOE ε4 in nonlobar ICH.
OBJECTIVE: Genetic variants ε2/ε4 within the APOE gene are established risk factors for lobar intracerebral hemorrhage (ICH). Published preliminary data suggest a potential role for APOE ε4 in risk of nonlobar ICH. We therefore investigated the role of APOE in recurrent nonlobar ICH, and sought to clarify whether effects of APOE on circulating lipids mediate this association. METHODS: Three hundred sixty-three survivors of nonlobar ICH were followed prospectively for ICH recurrence, with APOE genotype determined at enrollment. All participants had clinical, demographic, and laboratory data captured at time of index ICH and during follow-up. Using a multivariate model, we performed association and interaction analyses of the relationships among APOE genotype, lipid levels, and recurrent nonlobar ICH. RESULTS: We observed 29 nonlobar ICH recurrences among 363 survivors. APOE ε4 was associated with recurrent nonlobar ICH (hazard ratio = 1.31; 95% confidence interval = 1.02-2.69; p = 0.038) after adjustment for age/sex/ethnicity and cardiovascular risk factors. Increasing low-density lipoprotein (LDL) levels were associated with decreased risk of recurrent nonlobar ICH (p = 0.027), as were decreasing HDL levels (p = 0.046). LDL levels modified the association of APOE ε4 with recurrent nonlobar ICH (mediation p < 0.05). No associations were identified between APOE ε2 and recurrent nonlobar ICH. CONCLUSION:APOE ε4 is associated with recurrent ICH in nonlobar brain regions, providing further evidence for its causal role in ICH unrelated to cerebral amyloid angiopathy. LDL levels modulated this effect, suggesting that circulating lipid levels may mediate a portion of the role of APOE ε4 in nonlobar ICH.
Authors: Rita V Krishnamurthi; Andrew E Moran; Mohammad H Forouzanfar; Derrick A Bennett; George A Mensah; Carlene M M Lawes; Suzanne Barker-Collo; Myles Connor; Gregory A Roth; Ralph Sacco; Majid Ezzati; Mohsen Naghavi; Christopher J L Murray; Valery L Feigin Journal: Glob Heart Date: 2014-03
Authors: Barbara L Trommer; Chirag Shah; Sung Hwan Yun; Georgi Gamkrelidze; Emily S Pasternak; Gui Lan Ye; Michelle Sotak; Patrick M Sullivan; Joseph F Pasternak; Mary Jo LaDu Journal: Neuroreport Date: 2004-12-03 Impact factor: 1.837
Authors: Alessandro Biffi; Christopher D Anderson; Jeremiasz M Jagiella; Helena Schmidt; Brett Kissela; Björn M Hansen; Jordi Jimenez-Conde; Caroline R Pires; Alison M Ayres; Kristin Schwab; Lynelle Cortellini; Joanna Pera; Andrzej Urbanik; Javier M Romero; Natalia S Rost; Joshua N Goldstein; Anand Viswanathan; Alexander Pichler; Christian Enzinger; Raquel Rabionet; Bo Norrving; David L Tirschwell; Magdy Selim; Devin L Brown; Scott L Silliman; Bradford B Worrall; James F Meschia; Chelsea S Kidwell; Joseph P Broderick; Steven M Greenberg; Jaume Roquer; Arne Lindgren; Agnieszka Slowik; Reinhold Schmidt; Daniel Woo; Jonathan Rosand Journal: Lancet Neurol Date: 2011-07-06 Impact factor: 44.182
Authors: Chia-Ling Phuah; Tushar Dave; Rainer Malik; Miriam R Raffeld; Alison M Ayres; Joshua N Goldstein; Anand Viswanathan; Steven M Greenberg; Jeremiasz M Jagiella; Björn M Hansen; Bo Norrving; Jordi Jimenez-Conde; Jaume Roquer; Alexander Pichler; Christian Enzinger; Joan Montaner; Israel Fernandez-Cadenas; Arne Lindgren; Agnieszka Slowik; Reinhold Schmidt; Alessandro Biffi; Natalia Rost; Carl D Langefeld; Hugh S Markus; Braxton D Mitchell; Brad B Worrall; Steven J Kittner; Daniel Woo; Martin Dichgans; Jonathan Rosand; Christopher D Anderson Journal: Brain Date: 2017-10-01 Impact factor: 13.501
Authors: Vignan Yogendrakumar; Andrew M Demchuk; Richard I Aviv; David Rodriguez-Luna; Carlos A Molina; Yolanda S Blas; Imanuel Dzialowski; Adam Kobayashi; Jean-Martin Boulanger; Cheemun Lum; Gord Gubitz; Vasantha Padma; Jayanta Roy; Carlos S Kase; Rohit Bhatia; Michael D Hill; Dar Dowlatshahi Journal: Eur Stroke J Date: 2017-06-15
Authors: Chia-Ling Phuah; Miriam R Raffeld; Alison M Ayres; M Edip Gurol; Anand Viswanathan; Steven M Greenberg; Alessandro Biffi; Jonathan Rosand; Christopher D Anderson Journal: Neurol Genet Date: 2016-06-23
Authors: Sandro Marini; Katherine Crawford; Andrea Morotti; Myung J Lee; Alessandro Pezzini; Charles J Moomaw; Matthew L Flaherty; Joan Montaner; Jaume Roquer; Jordi Jimenez-Conde; Eva Giralt-Steinhauer; Roberto Elosua; Elisa Cuadrado-Godia; Carolina Soriano-Tarraga; Agnieszka Slowik; Jeremiasz M Jagiella; Joanna Pera; Andrzej Urbanik; Alexander Pichler; Björn M Hansen; Jacob L McCauley; David L Tirschwell; Magdy Selim; Devin L Brown; Scott L Silliman; Bradford B Worrall; James F Meschia; Chelsea S Kidwell; Fernando D Testai; Steven J Kittner; Helena Schmidt; Christian Enzinger; Ian J Deary; Kristiina Rannikmae; Neshika Samarasekera; Rustam Al-Shahi Salman; Catherine L Sudlow; Catharina J M Klijn; Koen M van Nieuwenhuizen; Israel Fernandez-Cadenas; Pilar Delgado; Bo Norrving; Arne Lindgren; Joshua N Goldstein; Anand Viswanathan; Steven M Greenberg; Guido J Falcone; Alessandro Biffi; Carl D Langefeld; Daniel Woo; Jonathan Rosand; Christopher D Anderson Journal: JAMA Neurol Date: 2019-04-01 Impact factor: 18.302
Authors: Patryk Kubiszewski; Lansing Sugita; Christina Kourkoulis; Zora DiPucchio; Kristin Schwab; Christopher D Anderson; M Edip Gurol; Steven M Greenberg; Anand Viswanathan; Jonathan Rosand; Alessandro Biffi Journal: JAMA Neurol Date: 2020-08-31 Impact factor: 18.302
Authors: Christopher D Anderson; Guido J Falcone; Chia-Ling Phuah; Farid Radmanesh; H Bart Brouwers; Thomas W K Battey; Alessandro Biffi; Gina M Peloso; Dajiang J Liu; Alison M Ayres; Joshua N Goldstein; Anand Viswanathan; Steven M Greenberg; Magdy Selim; James F Meschia; Devin L Brown; Bradford B Worrall; Scott L Silliman; David L Tirschwell; Matthew L Flaherty; Peter Kraft; Jeremiasz M Jagiella; Helena Schmidt; Björn M Hansen; Jordi Jimenez-Conde; Eva Giralt-Steinhauer; Roberto Elosua; Elisa Cuadrado-Godia; Carolina Soriano; Koen M van Nieuwenhuizen; Catharina J M Klijn; Kristiina Rannikmae; Neshika Samarasekera; Rustam Al-Shahi Salman; Catherine L Sudlow; Ian J Deary; Andrea Morotti; Alessandro Pezzini; Joanna Pera; Andrzej Urbanik; Alexander Pichler; Christian Enzinger; Bo Norrving; Joan Montaner; Israel Fernandez-Cadenas; Pilar Delgado; Jaume Roquer; Arne Lindgren; Agnieszka Slowik; Reinhold Schmidt; Chelsea S Kidwell; Steven J Kittner; Salina P Waddy; Carl D Langefeld; Goncalo Abecasis; Cristen J Willer; Sekar Kathiresan; Daniel Woo; Jonathan Rosand Journal: Ann Neurol Date: 2016-10-19 Impact factor: 10.422